Arkolith/Insider Trading/MURA/Form 4

Goodman Vicki L

Chief Medical OfficerMural Oncology plc (MURA) · full profile →Form 4 · filed Nov 8, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$17K
Net Open-Market Flow
-$17K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2024Sell(S)5K$3.33$17K68K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-124041) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML